Announcements Trials
Browse Landscape

Status

Terminated 2Recruiting 2Unknown 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 5

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 4Tumor-Agnostic 3Thoracic 2Other hematologic neoplasm 2Plasma cell 1Myeloid 1Head & Neck 1Classical hematology 1Breast 1

Conditions

Prostatic Neoplasms 4Urinary Bladder Neoplasms 1Chronic Disease 1Adenocarcinoma 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Registries × Genitourinary × Clear all
NCT03413982 2026-03-10

GUB-BCR-001

University of Kansas Medical Center

Recruiting
1,000 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03553732 2022-08-04

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

University of California, San Francisco

Terminated
48 enrolled
Genitourinary

Chronic Disease, Prostatic Neoplasms

NCT00850941 2019-05-15

Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy

M.D. Anderson Cancer Center

Unknown
146 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT02865330 2018-02-12

Spanish Urological Association Registry of Patients on Active Surveillance

Fundación Instituto Valenciano de Oncología

Recruiting
946 enrolled
Genitourinary

Prostatic Neoplasms

NCT02454595 2017-09-05

Registry to Measure the Impact of Adding Genomic Testing

Myriad Genetic Laboratories, Inc.

Terminated
116 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡